2025 HCPCS Code J3140
Injection, testosterone suspension, up to 50 mg
TAGS: testosterone| Notice | HCPCS J3140 terminated on December 31, 2014. |
| Short Description | Testosterone suspension inj |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 1982 |
| HCPCS Action Effective Date | January 01, 2015 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J2280 - Inj, moxifloxacin 100 mg
- J2281 - Inj moxifloxacin (fres kabi)
- J2290 - Inj, nafcillin sodium, 20 mg
- J2291 - Inj, nafcillin (baxter) 20mg
- J2300 - Inj nalbuphine hydrochloride
- J2305 - Inj, nitroglycerin, 5 mg
- J2310 - Inj naloxone hydrochloride
- J2311 - Inj, naloxone hcl (zimhi)
- J2312 - Inj naloxone hcl nos, 0.01mg
- J2313 - Inj, naloxone (zimhi) 0.01mg
- J2315 - Naltrexone, depot form
- J2320 - Nandrolone decanoate 50 mg
- J2323 - Natalizumab injection
- J2325 - Nesiritide injection
- J2326 - Inj, nusinersen, 0.1mg
- J2327 - Inj risankizumab-rzaa 1 mg
- J2329 - Inj ublituximab-xiiy, 1 mg
- J2350 - Injection, ocrelizumab, 1 mg
- J2351 - Inj ocrelizumab 1mg hya-ocsq
- J2353 - Octreotide injection, depot